Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other financing activities (2011 - 2022)

Nephros' quarterly Other financing activities came in at $188000.0 in Q1 2022, up 18700.0% quarter-over-quarter from $1000.0 in Q4 2019.

Nephros has reported Other financing activities for 4 years, with the latest figure at $188000.0 in Q1 2022.

  • For the quarter ending Q1 2022, Other financing activities changed N/A year-over-year to $188000.0; the trailing twelve-month figure through Dec 2022 stood at $188000.0 (changed N/A YoY), and the FY2022 full-year result was $188000.0, changed N/A from the prior year.
  • Other financing activities for Q1 2022 stood at $188000.0, up from $1000.0 in the prior quarter.
  • The five-year high for Other financing activities was $188000.0 in Q1 2022, with the low at $1000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 188,000.00
Mar 31, 2022 188,000.00
Dec 31, 2019 1,000.00
Dec 31, 2019 1,000.00
Dec 31, 2013 195,000.00
Dec 31, 2013 195,000.00
Mar 31, 2013 204,000.00
Mar 31, 2013 204,000.00
Mar 31, 2011 140,000.00
Mar 31, 2011 140,000.00